Log in to your IBTimes Account

close
ID
Password
  • Set your IBTimes.com Edition

Smithfield Foods loss less than expected



By Bob Burgdorfer
16 June 2009 @ 11:24 am ET

CHICAGO - Smithfield Foods Inc posted a smaller-than-expected quarterly loss on Tuesday on better-than-anticipated margins in its hog and pork businesses, but high feed costs weighed on results.

Profits on pork sales were down due to the recession, but the packaged meats segment of that unit had record earnings.

Influenza A H1N1, commonly called swine flu, did not affect the quarter, which ran through May 3, but did hurt business later in May. The flu's impact on domestic sales is lessening, but continues to restrict exports, specifically to China, the company said.

While feed costs should moderate going forward, Smithfield said it would reduce its sow herd an additional 3 percent following a previous 10 percent reduction.

"I am pleased to report that we are continuing discussions regarding refinancing with various lenders, well in advance of current maturities," Chief Executive C. Larry Pope said in a statement.

The company's financials and debt have been a concern of analysts and on Tuesday it reported more than $1.1 billion in liquidity at the end of the fiscal year and had pared debt by more than $890 million.

"Both the hog production and pork processing businesses posted better margins than we anticipated," Ken Goldman, J.P. Morgan analyst, said in a note.

The Smithfield, Virginia-based company reported a loss of $78.8 million, or 55 cents per share, for the fourth quarter that ended May 3, compared with a year-ago profit of $2.4 million, or 2 cents per share

Revenue was $2.85 billion, compared with the year ago's $2.87 billion.

This year's quarterly results include a one-time gain of $13.1 million for foreign tax credits.

Copyright 2009 Thomson Reuters. All rights reserved.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name

  • International Business Times Secutiry Check

advertisement
More Investing
The world's two largest diversified healthcare companies struck deals on Monday that will propel them into vaccines, a red-hot area for investors because...
U.S. healthcare companies Abbott Laboratories <ABT.N> and Johnson & Johnson <JNJ.N> announced deals worth almost 5 billion euros ($7.3 bi...
U.S. healthcare companies Abbott Laboratories <ABT.N><ABT.F> and Johnson & Johnson <JNJ.N> announced deals worth almost 5 billion e...

advertisement
 
IBTimes.com Web
Partners
International Business Times© Copyright 2010 Intertnational Business Times. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives